Related Experiment Video
Updated: May 7, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Advances in cellular reprogramming: moving toward a reprieve from immunogenicity
Thomas F Gallegos1, Ignacio Sancho-Martinez, Juan Carlos Izpisua Belmonte
1Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Somatic cell reprogramming offers therapeutic potential but faces safety hurdles like immunogenicity and tumorigenicity. Future strategies may combine reprogramming with immunology for novel disease treatments.
Area of Science:
- Stem cell biology
- Immunology
- Regenerative medicine
Background:
- Somatic cell nuclear reprogramming advances disease modeling and cell therapies.
- Concerns regarding the safety of stem cell derivatives, including immunogenicity and tumorigenicity, hinder clinical translation.
Purpose of the Study:
- To review current knowledge on stem cell reprogramming, focusing on clinical translation barriers.
- To explore the immunogenicity and tumorigenicity of reprogrammed cells.
- To discuss the potential of reprogramming in immunology and immunotherapeutics.
Main Methods:
- Literature review of stem cell reprogramming and immunology.
- Analysis of safety concerns (immunogenicity, tumorigenicity).
- Overview of induced pluripotent stem cells (iPSCs) for immunotherapies.
Main Results:
- Reprogramming technologies show promise but face safety challenges.
- Immunogenicity and tumorigenicity are key concerns for clinical application.
- Reprogramming offers novel strategies for immune modulation and immunotherapies.
Conclusions:
- Addressing safety concerns is crucial for widespread clinical adoption of reprogramming.
- Combining reprogramming with immunological strategies presents groundbreaking therapeutic potential.
- Induced pluripotent stem cells with engineered immune receptors could advance future immunotherapies.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Introduction to Nuclear Reprogramming
Cell-mediated Immune Responses

